^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Liquid Trace™ Hematology

    Company:
    Genomic Testing Cooperative
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    GTC’s Liquid Trace Hematology is a pan-cancer highly sensitive test evaluating cfRNA and cfDNA providing highly informative data that can be used for diagnoses, evaluating the host immune response, and identifying biomarkers for predicting responses to various therapies.
    Cancer:
    Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
    Gene:
    ABL1 (ABL proto-oncogene 1), CREBBP (CREB binding protein), GNAS (GNAS Complex Locus), NF2 (Neurofibromin 2), SMC3 (Structural Maintenance Of Chromosomes 3)
    Method:
    Liquid biopsy / cfRNA / cfDNA